Mar 9, 2026

Featuring an interview with Dr Hanny Al-Samkari, including the following topics:

• VAYHIT1: A multicenter randomized, double-blind, Phase III trial evaluating ianalumab versus placebo in addition to first-line corticosteroids for patients with primary immune thrombocytopenia (ITP) (0:00)
• Secondary analysis results from...

Mar 7, 2026

Featuring perspectives from Prof Nicoletta Colombo and Dr Kathleen N Moore, including the following topics:

• Introduction (0:00)
• Promising Novel Agents and Strategies Under Investigation in Ovarian Cancer (2:35)
• Current Management of Newly Diagnosed and Relapsed/Refractory Ovarian Cancer(41:48)

CME information and...

Mar 6, 2026

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Ovarian Cancer | Faculty Presentation 2: Promising Novel Agents and Strategies Under Investigation in Ovarian Cancer — Nicoletta Colombo, MD

CME information and select...

Mar 6, 2026

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Ovarian Cancer | Faculty Presentation 1: Current Management of Newly Diagnosed and Relapsed/Refractory Ovarian Cancer — Angeles Alvarez Secord, MD, MHSc

CME information and select...

Mar 6, 2026

Featuring an interview with Dr Christopher Lieu, including the following topics:

• Historical approach to the adjuvant treatment of localized colorectal cancer (CRC) (0:00)
• Perspectives on earlier-onset colorectal cancer and potential drivers; management of oligometastatic disease (13:16)
• Overview of cell-free DNA...